Showing 2641-2650 of 3763 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-34/23707/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-13/23272/A Rational Criteria: When Not to Treat Warts
https://practicaldermatology.com/topics/infections-infectious-disease/a-rational-criteria-when-not-to-treat-warts/23813/How to decide which warts to let resolve on their own.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.Etiology, Autoinoculation, and Transmission: What Wart Patients Need to Know
https://practicaldermatology.com/topics/infections-infectious-disease/etiology-autoinoculation-and-transmission-what-wart-patients-need-to-know/23613/Taking time to educate patients can decrease their embarrassment and can lead them to share useful information.From Clinician to Investigator: Staying Ethical in Industry-Sponsored Trials
https://practicaldermatology.com/topics/practice-management/from-clinician-to-investigator-staying-ethical-in-industry-sponsored-trials/23978/Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.The Dermatology & Aesthetics Markets: Retained Value In A New Normal
https://practicaldermatology.com/topics/practice-management/the-dermatology-aesthetics-markets-retained-value-in-a-new-normal/23583/Understanding new trends helps strengthen the dermatology and aesthetics markets, as well as shape practice decisions for the future.Breaking the Itch-Scratch Cycle
https://practicaldermatology.com/topics/atopic-dermatitis/breaking-the-itch-scratch-cycle/23922/Upadacitinib’s rapid relief for patients with moderate-to-severe atopic dermatitis.